Correlations between the symptoms of insomnia, depression, sleep quality, antitumor necrosis factor therapy, and disrupted circadian clock gene expression in inflammatory bowel disease

被引:7
|
作者
Sochal, Marcin [1 ]
Binienda, Agata [2 ]
Ditmer, Marta [1 ]
Malecka-Wojciesko, Ewa
Bialasiewicz, Piotr [1 ]
Fichna, Jakub [2 ]
Talar-Wojnarowska, Renata [3 ]
Gabryelska, Agata [1 ]
机构
[1] Med Univ Lodz, Dept Sleep Med & Metab Disorders, Ul Mazowiecka 6-8, PL-90001 Lodz, Poland
[2] Med Univ Lodz, Dept Biochem, Lodz, Poland
[3] Med Univ Lodz, Dept Digest Tract Dis, Lodz, Poland
来源
POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ | 2023年 / 133卷 / 10期
关键词
antitumor necrosis factor therapy; circadian locomotor output cycles kaput; depression; inflammatory bowel disease; insomnia; DISTURBANCE; VALIDATION; INSTRUMENT; RHYTHMS; INDEX; PER2;
D O I
10.20452/pamw.16487
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
INTRODUCTION Inflammatory bowel disease (IBD) might be accompanied by emotional disturbances. Circadian rhythm genes, such as brain and muscle ARNT-Like 1 (BMAL1), circadian locomotor output cycles kaput (CLOCK), neuronal PAS domain protein 2 (NPAS2), or nuclear receptor subfamily 1 group D member 1 (NR1D1) are related to inflammation and psychiatric symptoms that might modulate their expression.OBJECTIVES The study aimed to compare the expression of the BMAL1, CLOCK, NPAS2, NR1D1 mRNA in IBD patients and healthy controls (HCs). We evaluated the association between the gene expression and the disease severity, anti tumor necrosis factor (TNF) therapy, sleep quality, insomnia, and depression.PATIENTS AND METHODS A total of 81 IBD patients and 44 HCs were recruited and classified according to the disease activity and IBD type (ulcerative colitis [UC] or Crohn disease [CD]). The participants filled out questionnaires assessing their sleep quality, daytime sleepiness, insomnia, and depression. Venous blood samples were collected, and the IBD patients on the anti-TNF therapy had their blood drawn before and after 14 weeks of the treatment.RESULTS In comparison with HCs, the IBD group had decreased expression of all studied genes apart from the BMAL1 gene. UC individuals with exacerbation had decreased expression of the CLOCK and the NPAS2 genes, as compared with the remission group. UC severity negatively correlated with the CLOCK, NPAS2, and NR1D1 mRNA levels. The IBD participants with depression symptoms had a decreased expression of the CLOCK and the NR1D1 genes, as compared with those without mood disturbances. Poor sleep quality was associated with a decreased expression of the NR1D1 gene. Biologic treatment decreased the expression of the BMAL1 gene. CONCLUSIONS Disruption of the clock gene expression might constitute a molecular background of sleep disorders and depression in IBD and might contribute to UC exacerbation.
引用
收藏
页数:9
相关论文
共 22 条
  • [1] Relation between Selected Sleep Parameters, Depression, Anti-Tumor Necrosis Factor Therapy, and the Brain-Derived Neurotrophic Factor Pathway in Inflammatory Bowel Disease
    Sochal, Marcin
    Ditmer, Marta
    Binienda, Agata
    Gabryelska, Agata
    Bialasiewicz, Piotr
    Talar-Wojnarowska, Renata
    Fichna, Jakub
    Malecka-Wojciesko, Ewa
    METABOLITES, 2023, 13 (03)
  • [2] Association between brain-derived neurotrophic factor and symptoms of insomnia and depression in inflammatory bowel disease (IBD) patients
    Sochal, M.
    Bialasiewicz, P.
    Gabryelska, A.
    Fichna, J.
    Talar-Wojnarowska, R.
    Malecka-Panas, E.
    EUROPEAN PSYCHIATRY, 2021, 64 : S554 - S554
  • [3] Management of sporotrichosis in patients with inflammatory bowel disease using biological therapy (antitumor necrosis factor)
    Godoy Finger, Ana
    Tavares Ferreira de Oliveira Cruz, Livia
    Rosevics, Leticia
    de Queiroz-Telles, Flavio
    Beiral Hammerle, Marcia
    Breda, Giovanni
    Kowalski Furlan, Thaisa
    Castro Tavares, Gabriel
    Cuzzi, Tullia
    Zaltman, Cyrla
    Ramos Jr, Odery
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2025, 37 (03) : 370 - 375
  • [4] Predicting durable response or resistance to antitumor necrosis factor therapy in inflammatory bowel disease
    Kopylov, Uri
    Seidman, Ernest
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2016, 9 (04) : 513 - 526
  • [5] Outcome of Pregnancy in Women with Inflammatory Bowel Disease Treated with Antitumor Necrosis Factor Therapy
    Schnitzler, Fabian
    Fidder, Herma
    Ferrante, Marc
    Ballet, Vera
    Noman, Maja
    Van Assche, Gert
    Spitz, Bernard
    Hoffman, Ilse
    Van Steen, Kristel
    Vermeire, Severine
    Rutgeerts, Paul
    INFLAMMATORY BOWEL DISEASES, 2011, 17 (09) : 1846 - 1854
  • [6] Relation between serum interleukin 33 concentration, depressive symptoms, and sleep quality in inflammatory bowel disease
    Sochal, Marcin
    Ditmer, Marta
    Malecka-Wojciesko, Ewa
    Gabryelska, Agata
    Talar-Wojnarowska, Renata
    Bialasiewicz, Piotr
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2023, 133 (09):
  • [7] Correlation Analysis Between Disease Activity and Anxiety, Depression, Sleep Disturbance, and Quality of Life in Patients with Inflammatory Bowel Disease
    Yu, Rong
    Liu, Chuan
    Zhang, Jixiang
    Li, Jiao
    Tian, Shan
    Ding, Fugui
    Liu, Zhengru
    Wang, Ting
    Liu, Zhongchun
    Jiang, Changqing
    Shi, Jie
    Wu, Kaichun
    Dong, Weiguo
    NATURE AND SCIENCE OF SLEEP, 2023, 15 : 407 - 421
  • [8] Associations between immune biomarkers and symptoms of anxiety, depression, and insomnia in paediatric inflammatory bowel disease: A preliminary longitudinal analysis
    Ballesio, Andrea
    Santamaria, Tiziana
    Furio, Silvia
    Parisi, Pasquale
    Polese, Daniela
    Micheli, Federica
    Baccini, Flavia
    Di Nardo, Giovanni
    Lombardo, Caterina
    PHYSIOLOGY & BEHAVIOR, 2024, 278
  • [9] Depressive Symptoms Predict Anti-tumor Necrosis Factor Therapy Noncompliance in Patients with Inflammatory Bowel Disease
    Alexis Calloway
    Robin Dalal
    Dawn B. Beaulieu
    Caroline Duley
    Kimberly Annis
    Lawrence Gaines
    Chris Slaughter
    David A. Schwartz
    Sara Horst
    Digestive Diseases and Sciences, 2017, 62 : 3563 - 3567
  • [10] Depressive Symptoms Predict Anti-tumor Necrosis Factor Therapy Noncompliance in Patients with Inflammatory Bowel Disease
    Calloway, Alexis
    Dalal, Robin
    Beaulieu, Dawn B.
    Duley, Caroline
    Annis, Kimberly
    Gaines, Lawrence
    Slaughter, Chris
    Schwartz, David A.
    Horst, Sara
    DIGESTIVE DISEASES AND SCIENCES, 2017, 62 (12) : 3563 - 3567